Background: The aryl hydrocarbon receptor (AHR) is a highly conserved ligand-dependent transcription factor, which recently gained recognition, beyond its role as a toxicity sensor, as a major player in different biological circumstances [1]. Our group and others have shown that AHR modulation in different scenarios, including by therapeutic drugs, impacts disease outcomes and treatment efficacy, in conditions ...